Gary L. Rosner logo  logo

Gary L. Rosner

Director, Division of Biostatistics and Bioinformatics, Department of Oncology, John Hopkins Medicine (USA)


Dr. Gary Rosner, Professor of Oncology, is Director of the Division of Biostatistics and Bioinformatics, in the Department of Oncology, since joining the faculty at Johns Hopkins University in February 2010. Dr. Rosner leads the Biostatistics Shared Resource in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

He received his Sc.D. in Biostatistics from the Harvard School of Public Health in 1985. He was a member of the faculties of Yale University, Duke University, and The University of Texas M. D. Anderson Cancer Center. He has been actively involved in collaborative research, teaching, and mentoring.

Dr. Rosner has extensive experience in clinical research. In addition to collaborating with clinical researchers at his home institutions, he was a faculty statistician in the Statistical Office of the Cancer and Leukemia Group B (CALGB) for 12 years. He is also an active member of theNIH-funded Pharmacogenetics Research Network (PGRN), collaborating with colleagues in the Pharmacogenetics of Anticancer Agent Research (PAAR) group and PAAR4Kids, a group studying the pharmacogenetics of anticancer agents used in pediatric oncology. Dr. Rosner’s biostatistical research concerns population pharmacokinetics, pharmacodynamic modeling, pharmacogenetics, Bayesian methods, the analysis of repeated measurement and longitudinal data, clinical trial design, and survival analysis.

Gary L. Rosner logo

Gary L. Rosner

Director, Division of Biostatistics and Bioinformatics, Department of Oncology, John Hopkins Medicine (USA)


 logo

Dr. Gary Rosner, Professor of Oncology, is Director of the Division of Biostatistics and Bioinformatics, in the Department of Oncology, since joining the faculty at Johns Hopkins University in February 2010. Dr. Rosner leads the Biostatistics Shared Resource in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

He received his Sc.D. in Biostatistics from the Harvard School of Public Health in 1985. He was a member of the faculties of Yale University, Duke University, and The University of Texas M. D. Anderson Cancer Center. He has been actively involved in collaborative research, teaching, and mentoring.

Dr. Rosner has extensive experience in clinical research. In addition to collaborating with clinical researchers at his home institutions, he was a faculty statistician in the Statistical Office of the Cancer and Leukemia Group B (CALGB) for 12 years. He is also an active member of theNIH-funded Pharmacogenetics Research Network (PGRN), collaborating with colleagues in the Pharmacogenetics of Anticancer Agent Research (PAAR) group and PAAR4Kids, a group studying the pharmacogenetics of anticancer agents used in pediatric oncology. Dr. Rosner’s biostatistical research concerns population pharmacokinetics, pharmacodynamic modeling, pharmacogenetics, Bayesian methods, the analysis of repeated measurement and longitudinal data, clinical trial design, and survival analysis.


Why WIN